Sanofi, Mylan Debate If EpiPen Competition Was A Price War Or A Monopoly

Mealey's (September 19, 2017, 2:52 PM EDT) -- TOPEKA, Kan. — A motion to dismiss an EpiPen antitrust lawsuit continued to play out in two federal courts Sept. 14 when defendant Sanofi-Aventis U.S. LLC filed its opposition and defendant...
To view the full article, register now.